SPY389.63+0.17 0.04%
DIA312.42-0.01 0.00%
IXIC11,354.62-33.88 -0.30%

--B. Riley Lowers OptimizeRx's PT to $71 from $102, Notes Volatility, Rerating Across Public Markets, Early Q1 Omicron Impact; Keeps Buy Rating

MT Newswires · 05/02/2022 04:34

Please log in to view news